No. 21A677

Teva Pharmaceuticals USA, Inc. v. GlaxoSmithKline LLC, et al.

Lower Court: Federal Circuit
Docketed: 2022-05-03
Status: Presumed Complete
Type: A
Experienced Counsel
Tags: None
Latest Conference: N/A

Question presented not available.

Docket Entries

2022-05-03
Application (21A677) granted by The Chief Justice extending the time to file until July 11, 2022.
2022-04-29
Application (21A677) to extend the time to file a petition for a writ of certiorari from May 12, 2022 to July 11, 2022, submitted to The Chief Justice.
Main DocumentLower Court Orders/OpinionsLower Court Orders/OpinionsLower Court Orders/Opinions

Attorneys

Teva Pharmaceuticals USA, Inc.
William McGinley Jay — Goodwin Procter, LLP, Petitioner